Why a Texas congressman believes Chinese biotechs are 'beating us on our ground game'

The skyrocketing use of Chinese biopharmas as a source of innovation for U.S. drug developers has been viewed with alarm among certain parts of the political establishment. But for Rep. | The “knowledge base is going to start shifting quickly to China,” Rep. Nathaniel Moran, R-Texas, a member of the House Select Committee on China, told Fierce.